This event gathers leading experts and professionals from the pharmaceutical and biotechnology sectors to delve into the complex and ever-evolving landscape of patent litigation in Europe.

Partner Ross Cummings will be speaking on a panel discussing recent antibody-related patent office decisions both in Europe and the US, with a particular focus on current best practices for drafting and examining antibody patents.

This conference aims to provide attendees with a comprehensive understanding of the current state of pharma and biotech patent litigation in Europe, equipping them with the knowledge to protect their innovations effectively and maintain a competitive edge in a rapidly advancing field.

If you are attending this event, we look forward to seeing you there.